SeaCrest Wealth Management’s ENDRA Life Sciences NDRA Stock Holding History

SeaCrest Wealth Management’s Portfolio NDRA Stock Details NDRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1	Closed	-$32K	–	1359
2019 Q1	$32K	Sell	1 -2	-67%	-$146K	0.01%	1090
2018 Q4	$181K	Hold	3	–	–	0.04%	447
2018 Q3	$321K	Hold	3	–	–	0.05%	369
2018 Q2	$234K	Buy	+3	New	+$243K	0.04%	438

Other funds holding NDRA

IAM

ICM Asset Management Spokane, Washington $18.1M AUM 30.29% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

BRWA

B. Riley Wealth Advisors Boca Raton, Florida $1.87B AUM 37.01% 1-Year Est. Return

WEC

Winslow Evans & Crocker Boston, Massachusetts $528M AUM 30.99% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

SeaCrest Wealth Management's NDRA Position: Q2 2019 in Review

SeaCrest Wealth Management sold out of ENDRA Life Sciences (NDRA) in Q2 2019, closing a stake of 1 share — an estimated $32K sold.

SeaCrest Wealth Management first reported a position in NDRA in Q2 2018 and held it in 4 quarters. The position peaked at $321K in Q3 2018. 6 funds tracked by Wall St. Rank hold NDRA as of Q2 2019.

SeaCrest Wealth Management reported no remaining ENDRA Life Sciences position as of Q2 2019 after selling out during the quarter.
SeaCrest Wealth Management sold 1 ENDRA Life Sciences share in Q2 2019, an estimated $32K.
SeaCrest Wealth Management first reported a position in ENDRA Life Sciences in Q2 2018 and held it in 4 quarters.
SeaCrest Wealth Management's ENDRA Life Sciences position peaked at $321K in Q3 2018.
6 funds tracked by Wall St. Rank held ENDRA Life Sciences as of Q2 2019.

Based on SeaCrest Wealth Management's 13F filing for Q2 2019, filed 19 Jul 2019.